FDA Peptide Reclassification 2026: What It Means for Providers New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA Peptide Reclassification: What This Means For Weight Loss, Recovery, And More The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions